Somatostatin treatment reduces the exaggerated response of adrenocorticotropin hormone and cortisol to corticotropin-releasing hormone in polycystic ovary syndrome

By Lanzone A.   Fulghesu A.M.   Guido M.   Cucinelli F.   Caruso A.   Mancuso S.  

Fertility and Sterility, Vol. 67, Iss. 1, 1997-01 ,pp. : 34-39

Elsevier

Access to resources Recommend Favorite

Polycystic ovary syndrome and metabolic syndrome

By Hayden Catherine J   Balen Adam H  

Expert Review of Obstretrics and Gynecology, Vol. 1, Iss. 2, 2006-11 ,pp. : 183-194

Informa Healthcare

Access to resources Recommend Favorite

A systematic review of the reproductive system effects of metformin in patients with polycystic ovary syndrome

By Costello M.F.   Eden J.A.  

Fertility and Sterility, Vol. 79, Iss. 1, 2003-01 ,pp. : 1-13

Elsevier

Access to resources Recommend Favorite

Polycystic ovary syndrome as a developmental disorder

By Goverde Angelique J   Westerveld H Egbertine   Verhulst Susanne M   Fauser Bart CJM  

Expert Review of Obstretrics and Gynecology, Vol. 3, Iss. 6, 2008-11 ,pp. : 775-787

Informa Healthcare

Access to resources Recommend Favorite

The metabolic aspects of polycystic ovary syndrome

By Yasmin Ephia   Balen Adam H  

Expert Review of Obstretrics and Gynecology, Vol. 6, Iss. 3, 2011-05 ,pp. : 331-341

Informa Healthcare

Access to resources Recommend Favorite